1. 176PClinical significance of RCAS1 and CD3 expression in non-small cell lung cancers in immunotherapy era. (23rd October 2018) Authors: Tsoukalas, N G; Aravantinou, E; Tsapakidis, K; Giaginis, C; Tolia, M; Binas, I; Baxevanos, P; Galanopoulos, M; Kiakou, M; Tsiatas, M; Kostakis, I; Nikolaou, C; Litos, I; Liontos, M; Tsiambas, E; Gioulbasanis, I; Sfiniadakis, I; Karameris, A; Kyrgias, G; Theocharis, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 368 Primary breast carcinosarcoma. (18th September 2019) Authors: Tsoukalas, N; Tsapakidis, K; Aravantinou-Fatorou, E; Baxevanos, P; Tolia, M; Binas, I; Kiakou, M; Galanopoulos, M; Kostakis, I; Tsiampas, E; Karameris, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P507 Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis. (25th January 2019) Authors: Viazis, N; Tsoukali, E; Galanopoulos, M; Pontas, C; Karampekos, G; Filippidis, G; Giouleme, O; Theocharis, G; Tzouvala, M; Archavlis, E; Christidou, A; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P654 Prevalence of Inflammatory Bowel Disease in young Greek Army male recruits from 2006 to 2018: a thirteen-year retrospective study from a tertiary center. (27th May 2021) Authors: Kyriakos, N; Papaefthymiou, A; Giakoumis, M; Galanopoulos, M; Galanis, P; Mylonas, I; Karatzas, P; Mantzaris, G; Liatsos, C Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P659 Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission. (25th January 2019) Authors: Viazis, N; Pontas, C; Gazouli, M; Tsigaridas, T; Tziortziotis, I; Chatzievangelinou, C; Gkeros, F; Vraka, M; Tsatsa, A; Tsoukali, E; Galanopoulos, M; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗